BRTX·090655606·US·equity·Healthcare - Biotechnology-13D/G
BRTX (BIORESTORATIVE THERAPIES INC) is held by 6 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($64,925), GEODE CAPITAL MANAGEMENT, LLC ($60,700), UBS Group AG ($27,154). Net institutional sentiment: Bullish.
See how BRTX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer